Publication | Open Access
Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy
113
Citations
33
References
2019
Year
This open-label study indicates favorable side effect profiles and clinical efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies for TK2 deficiency. ANN NEUROL 2019;86:293-303.
| Year | Citations | |
|---|---|---|
Page 1
Page 1